Blau Camps - Publications

Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Journal: Alimentary pharmacology & therapeutics

Published: March 28, 2026

Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.

Journal: Alimentary pharmacology & therapeutics

Published: March 03, 2025

Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 17, 2024

HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.

Journal: The American journal of gastroenterology

Published: March 27, 2024

Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.

Journal: Postgraduate medical journal

Published: February 10, 2024

Definition of a microbial signature as a predictor of endoscopic post-surgical recurrence in patients with Crohn's disease.

Journal: Frontiers in molecular medicine

Published: September 16, 2022

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.

Journal: Frontiers in medicine

Published: November 28, 2021

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.

Journal: Journal of Crohn's & colitis

Published: April 16, 2021

Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.

Journal: Alimentary pharmacology & therapeutics

Published: December 19, 2020

The EPAGE guidelines are not an effective strategy for managing colonoscopies during the COVID-19 pandemic.

Journal: Gastroenterologia y hepatologia

Published: July 03, 2020

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.

Journal: Journal of Crohn's & colitis

Published: May 08, 2019

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Journal: Antiviral research

Published: April 15, 2019